PAPER O'Neill C, Cowburn RF, Bonkale WL, Ohm TG, Fastbom J, Carmody M, Kelliher M

Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease.

Biochem Soc Symp. 2001;(67):177-94. PubMed.

PAPER Duff K

Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis.

Biochem Soc Symp. 2001;(67):195-202. PubMed.

PAPER Dewachter I, Moechars D, Van Dorpe J, Tesseur I, Van den Haute C, Spittaels K, Van Leuven F

Modelling Alzheimer's disease in multiple transgenic mice.

Biochem Soc Symp. 2001;(67):203-10. PubMed.

PAPER Georgopoulou N, McLaughlin M, McFarlane I, Breen KC

The role of post-translational modification in beta-amyloid precursor protein processing.

Biochem Soc Symp. 2001;(67):23-36. PubMed.

PAPER Neve RL, McPhie DL, Chen Y

Alzheimer's disease: dysfunction of a signalling pathway mediated by the amyloid precursor protein?

Biochem Soc Symp. 2001;(67):37-50. PubMed.

PAPER Goedert M, Spillantini MG

Tau gene mutations and neurodegeneration.

Biochem Soc Symp. 2001;(67):59-71. PubMed.

PAPER Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M

Sites of phosphorylation in tau and factors affecting their regulation.

Biochem Soc Symp. 2001;(67):73-80. PubMed.

PAPER Brion JP, Anderton BH, Authelet M, Dayanandan R, Leroy K, Lovestone S, Octave JN, Pradier L, Touchet N, Tremp G

Neurofibrillary tangles and tau phosphorylation.

Biochem Soc Symp. 2001;(67):81-8. PubMed.

PAPER Fraser PE, Yu G, Lévesque L, Nishimura M, Yang DS, Mount HT, Westaway D, St George-Hyslop PH

Presenilin function: connections to Alzheimer's disease and signal transduction.

Biochem Soc Symp. 2001;(67):89-100. PubMed.

PAPER Pilger C, Bartolucci C, Lamba D, Tropsha A, Fels G

Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.

J Mol Graph Model. 2001;19(3-4):288-96, 374-8. PubMed.

PAPER Liou YJ, Lai IC, Hong CJ, Liu HC, Liu TY, Tsai SJ

Association analysis of the partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease.

Dement Geriatr Cogn Disord. 2001 Sep-Oct;12(5):301-4. PubMed.

PAPER Nicosia F, Alberici A, Benussi L, Gasparini L, Ghidoni R, Mazzoli F, Zanetti O, Frisoni GB, Geroldi C, Binetti G

Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer's disease.

Dement Geriatr Cogn Disord. 2001 Sep-Oct;12(5):305-8. PubMed.

PAPER McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C

Homocysteine and cognitive decline in healthy elderly.

Dement Geriatr Cogn Disord. 2001 Sep-Oct;12(5):309-13. PubMed.

PAPER Tarkowski E, Liljeroth AM, Nilsson A, Minthon L, Blennow K

Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease.

Dement Geriatr Cogn Disord. 2001 Sep-Oct;12(5):314-7. PubMed.

PAPER Kaneko I, Morimoto K, Kubo T

Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.

Neuroscience. 2001;104(4):1003-11. PubMed.